期刊文献+

细胞角蛋白片段19等指标在非小细胞肺癌诊断中的应用 被引量:2

Application of the Detection of CK-19 and Other Assiociated Laboratory Items in the Diagnosis of Non-small Cell Lung Cancer
下载PDF
导出
摘要 目的 研究胸水和血清细胞角蛋白片段 19(CK - 19)等指标在非小细胞性肺癌 (NSCLC)实验室诊断中的应用价值 .方法 采用ELISA法检测 4 5例NSCLC、5 0例良性肺疾病患者血清和胸水中CK - 19水平 ,30例健康体检者血清CK - 19水平 ,同步测定了乳酸脱氢酶 (LDH)、腺苷脱氨酶 (ADA)、C反应蛋白 (CRP)、癌胚抗原 (CEA)、免疫球蛋白E(IgE)水平 ,进行显著性检验及相关性分析 .结果 NSCLC组血清和胸水中CK - 19、CEA和LDH水平均明显高于良性肺疾病组 (p <0 .0 5 ) ,而血清ADA水平均低于良性肺疾病组和健康对照组 (p <0 .0 5 ) .良性肺疾病组血清和胸水CRP水平明显高于NSCLC组 (p <0 .0 5 ) .胸水中CK - 19水平与血清CK - 19水平高度相关 (NSCLC组r=0 .86 8;良性肺疾病组r=0 .5 4 6 2 ) .胸水和血清CK - 19对肺癌的诊断敏感性、特异性和准确性分别为 93.3%和 71.1%、91.7%和 87.5 %、92 %和 81.6 % .结论 胸水和血清CK - 19检测对NSCLC的诊断是一个较好的指标 。 Objective To detect cytokeratin 19 fragment (CK-19) and other associated biochemical items and analysis their clinical significance for specific diagnosis of Non-small cell lung cancer (NSCLC) in the laboratory. Methods The level of CK-19 in the pleural effusion (PE) and serum of 45 lung cancer patients,50 benign lung disease patients, and the level of CK-19 in the serum of 30 healthy people control were detected by ELISA, and the correlation of these parameters was analysised.Other associated laboratory items including LDH, ADA, CRP, CEA, IgE were assayed in the PE and serum of these patients. Results The level of CK-19,CEA and LDH in the NSCLC group were higher than there in benign lung disease group and healthy control group(p<0.05),but the level of ADA in the cancer group were lower than that in the benign lung disease group and healthy control group(p<0.05).The level of CRP was increased significantly in the benign group(p<0.05).The level of CK-19 in the PE were significantly correlated with that in the serum of patients with lung cancer (r=0.868 ) and patients with benign lung disease(r=0.5462 ).The sensitivity, specificity, and accuracy of CK-19 in the PE and serum as a diagnostic test for NSCLC was 93.3%,71.1%,91.7% and 87.5%,92%, 81.6% respectively. Conclusions Pleural effusion CK-19 may be a useful test for diagnosing NSCLC. It may be more benificial for diagnosing lung cancer measuring the CK-19 and other associated laboratory items combinatorial optimation.
出处 《现代临床医学生物工程学杂志》 2004年第2期122-124,共3页 Journal of Modern Clinical Medical Bioengineering
关键词 细胞角蛋白19 非小细胞性肺癌 肿瘤标志物 胸水 Cytokeratin 19 fragment Non small cell lung cancer Tumor marker Pleural effusion
  • 相关文献

参考文献8

  • 1Dingemans AMC,Brakenhoff RH, Postmus PE, et al. Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients[J]. laboratory investigation.1997,77(3):213.
  • 2Sun,S S,Hsieh J F,Tsai S C,et al. Cytokeratin fragment 19 and squamous cell carcinoma antigen for early prediction of recurrence of squamous cell lung carcinoma[J]. American Journal of Clinical Oncology,2000,23(3):241.
  • 3Ginsberg RJ, Kris MG,Armstrong JG. Cancer of the lung[J].In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. Philadelphia: Lippincott, 1993,673.
  • 4Buccheri G, Torchio P, Ferrigno D.Clinical equivalence of two cytokeratin markers in non-small cell lung cancer: A Study of tissue polypeptide antigen and cytokeratin 19 fragments[J]. Chest,2003,124(2):622.
  • 5Pariente J L, Bordenave L, Jacob F, et al. Analytical and prospective evaluation of urinary cytokeratin 19 fragment in bladder cancer[J]. Journal of Urology,2000,163:1116.
  • 6Nagai T, Murota M, Nishioka M,et al. Elevation of cytokeratin 19 fragment in serum in patients with hepatoma: its clinical significance[J]. European Journal of Gastroenterology &amp; Hepatology, 2001,13(2):157.
  • 7Nakayama M,Satoh H, Ishikawa H,et al. Cytokeratin 19 fragment in patients with nonmalignant respiratory diseases[J]. Chest,2003, 123(6):2001.
  • 8谷旭红,阎振元,周清龚,杏月.腺苷脱氨酶与癌胚抗原的测定在结核性与癌性胸水鉴别诊断中的意义[J].河南诊断与治疗杂志,2002,16(6):402-403. 被引量:7

二级参考文献4

  • 1Giusti G. Methods of enzymatic analysis. Bergmeger H U New York: Acad. Presss Inc, 1974 : 1092.
  • 2程明.CEA—EIA试药盒的研制及临床应用.北京:卫生部北京生物制品研究所,1981:25.
  • 3Piras MA. Adenosine deaminase activity in pleural effusion aid to differential diagnosis. Br Med J, 1978,2 : 1751.
  • 4王北宁,曾逦.胸水中腺苷脱氨酶活性测定的研究[J].中华结核和呼吸杂志,1990,13(2):76-77. 被引量:9

共引文献6

同被引文献55

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部